<SEC-DOCUMENT>0001193125-21-206427-index.html : 20210701
<SEC-HEADER>0001193125-21-206427.hdr.sgml : 20210701
<ACCEPTANCE-DATETIME>20210701164435
ACCESSION NUMBER:		0001193125-21-206427
CONFORMED SUBMISSION TYPE:	8-K/A
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20210625
ITEM INFORMATION:		Changes in Registrant's Certifying Accountant
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210701
DATE AS OF CHANGE:		20210701

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Millendo Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001544227
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				451472564
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35890
		FILM NUMBER:		211066530

	BUSINESS ADDRESS:	
		STREET 1:		110 MILLER AVENUE, SUITE 100
		CITY:			ANN ARBOR
		STATE:			MI
		ZIP:			48104
		BUSINESS PHONE:		734-845-9000

	MAIL ADDRESS:	
		STREET 1:		110 MILLER AVENUE, SUITE 100
		CITY:			ANN ARBOR
		STATE:			MI
		ZIP:			48104

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	OvaScience, Inc.
		DATE OF NAME CHANGE:	20120308
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K/A
<SEQUENCE>1
<FILENAME>d12343d8ka.htm
<DESCRIPTION>8-K/A
<TEXT>
Document 1 - file: d12343d8ka.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-16.1
<SEQUENCE>2
<FILENAME>d12343dex161.htm
<DESCRIPTION>EX-16.1
<TEXT>
Document 2 - file: d12343dex161.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>d12343dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
Document 3 - file: d12343dex991.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>4
<FILENAME>d12343dex992.htm
<DESCRIPTION>EX-99.2
<TEXT>
Document 4 - file: d12343dex992.htm

</DOCUMENT>
</SEC-DOCUMENT>